Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.928
-0.013 (-1.35%)
At close: Dec 20, 2024, 4:00 PM
0.987
+0.058 (6.27%)
After-hours: Dec 20, 2024, 5:42 PM EST
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Nektar Therapeutics stock have an average target of 4.00, with a low estimate of 1.00 and a high estimate of 7.00. The average target predicts an increase of 330.90% from the current stock price of 0.93.
Analyst Consensus: Buy
* Price targets were last updated on Nov 4, 2024.
Analyst Ratings
The average analyst rating for NKTR stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 2 | 1 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +654.07% | Nov 4, 2024 |
| BTIG | BTIG | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +330.90% | Sep 30, 2024 |
| Jefferies | Jefferies | Hold Maintains $0.5 → $1 | Hold | Maintains | $0.5 → $1 | +7.72% | Mar 6, 2024 |
| JP Morgan | JP Morgan | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Nov 20, 2023 |
| TD Cowen | TD Cowen | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Nov 9, 2023 |
Financial Forecast
Revenue This Year
101.70M
from 90.12M
Increased by 12.85%
Revenue Next Year
97.75M
from 101.70M
Decreased by -3.89%
EPS This Year
-0.77
from -1.45
EPS Next Year
-0.81
from -0.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 143.8M | 136.6M | 135.1M | |||
| Avg | 101.7M | 97.7M | 97.6M | |||
| Low | 85.1M | 66.6M | 55.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 59.5% | 34.3% | 38.2% | |||
| Avg | 12.8% | -3.9% | -0.1% | |||
| Low | -5.6% | -34.5% | -42.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.61 | -0.67 | -0.42 |
| Avg | -0.77 | -0.81 | -0.71 |
| Low | -0.81 | -0.96 | -0.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.